Phase 1/2, dose-escalation study of oral NS-018 in patients with primary myelofibrosis (PMF), post-polycythemia vera MF (post-PV MF), or post-essential thrombocythemia MF(post-ET MF)
作者
Srđan Verstovšek,Moshe Talpaz,Ellen K. Ritchie,Martha Wadleigh,Olatoyosi Odenike,Catriona Jamieson,Brady L. Stein,Tomonori Uno,Ruben A. Mesa